Sai Life Sciences
Sai Life Sciences, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1999, the company has established itself as a leading Contract Research and Manufacturing Services (CRAMS) provider, catering to global clients in drug discovery, development, and manufacturing. With a strong presence in key operational regions including North America and Europe, Sai Life Sciences offers a comprehensive range of services, from custom synthesis to formulation development. The company is recognised for its commitment to quality and innovation, which has earned it a solid market position and numerous accolades within the industry. Sai Life Sciences continues to drive advancements in life sciences, making significant contributions to the development of new therapeutics.
DitchCarbon Score
How does Sai Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sai Life Sciences's score of 26 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sai Life Sciences's reported carbon emissions
In 2023, Sai Life Sciences reported total carbon emissions of approximately 30,000,800 kg CO2e, comprising 12,610,200 kg CO2e from Scope 1, 17,536,600 kg CO2e from Scope 2, and a negative contribution of 4,050,000 kg CO2e from Scope 3 emissions. This indicates a commitment to managing and reducing their carbon footprint across various operational scopes. The company has shown a progressive reduction in emissions over the years. For instance, in 2022, their total emissions were about 25,000,930 kg CO2e, with Scope 1 and 2 emissions at 9,837,930 kg CO2e and 16,061,000 kg CO2e, respectively. This trend reflects their ongoing efforts to enhance sustainability within the pharmaceutical and biotechnology sector. Sai Life Sciences has committed to near-term climate targets, although specific reduction targets have not been disclosed. They are actively working towards improving their sustainability practices, as indicated by their participation in climate initiatives. However, they have not yet committed to a net-zero target. Overall, Sai Life Sciences is making strides in addressing climate change through emissions tracking and reduction initiatives, aligning with industry standards for environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 14,682,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 20,320,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | -0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sai Life Sciences is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
